2 unknown, 1 completed, 1 not yet recruiting, 1 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 2, Completed 1, Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Experimental drug: new trials by email Literature Review of Experimental drug trials Research Report on Experimental drug
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC Experimental drug - Locally Advanced Nasopharyngeal Carcinoma | Phase 2 | Not yet recruiting | Zhejiang Cancer Hospital | 58 | 2024-12-31 | 2024-12-30 |
| Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status Experimental drug - Colorectal Cancer, Liver Metastases | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 40 | 2022-10-01 | 2022-06-08 |
| NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19) Placebo, Experimental drug - COVID-19 Pandemic | Phase 1 / Phase 2 | Terminated | Medesis Pharma SA | 7 | 2022-02-04 | 2023-10-26 |
| IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS. Experimental drug - SARS Virus | Phase 2 | Unknown | Versailles Hospital | 99 | 2020-09-01 | 2020-08-07 |
| Stannsoporfin With Light Therapy for Newborn Babies With Jaundice Phototherapy, Stannsoporfin, Placebo - Jaundice, Neonatal, Hyperbilirubinemia, Neonatal | Phase 2 | Completed | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 91 | 2013-10-16 | 2020-02-06 |
COVID-19 (1) · Colorectal Neoplasms (1) · Glucosephosphate Dehydrogenase Deficiency (1) · Hyperbilirubinemia, Neonatal (1) · Jaundice, Neonatal (1) · Severe Acute Respiratory Syndrome (1)
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (1) · Medesis Pharma SA (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Versailles Hospital (1) · Zhejiang Cancer Hospital (1)
China (2) · Brazil (1) · France (1) · United States (1)